Reviewing how the drug can be incorporated into care
Study highlights benefits of nephrologist-led urine sediment analysis
The multidisciplinary research team reported their findings in JAMA
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Research findings reinforce the importance of patient selection and pre-emptive interventions
APE2 may hold the key to reducing cisplatin toxicity
Nearly 30 years of data validate this cost-efficient in-house alternative
Nephrologists discuss the most recent practice guidelines
Pathogenesis and optimal management of acute kidney injury in COVID-19
A nephrologist at Cleveland Clinic shares possible theories
